Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient

Bortezomib, an inhibitor of 26S proteosome, is recently approved treatment option for multiple myeloma. Thalidomide, a drug with immunomodulating and antiangiogenic effects, has also shown promise as an effective treatment in multiple myeloma. Pulmonary complications are believed to be rare, especia...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kang, Wonseok, Kim, Jin Seok, Cho, Sang Ho, Kim, Sung Kyu, Chang, Joon, Park, Moo Suk
Format: Artigo
Sprog:Inglês
Udgivet: Yonsei University College of Medicine 2010
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852803/
https://ncbi.nlm.nih.gov/pubmed/20376900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2010.51.3.448
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker